Table of contents
Volume 98, Issue 4
Published online 19 February 2008 (677-855)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor |
Book Review
Reviews
Targeting telomerase for cancer therapeutics FREE
J W Shay and W N Keith
Br J Cancer 98: 677-683; advance online publication, January 29, 2008; doi:10.1038/sj.bjc.6604209
Clinical implications of mutational analysis in gastrointestinal stromal tumours FREE
A Hoeben, P Schöffski and M Debiec-Rychter
Br J Cancer 98: 684-688; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604217
Clinical Studies
Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma FREE
M Früh, W Zhou, R Zhai, L Su, R S Heist, J C Wain, N S Nishioka, T J Lynch, F A Shepherd, D C Christiani and G Liu
Br J Cancer 98: 689-692; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604234
Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer FREE
I Sekine, H Nokihara, K Takeda, Y Nishiwaki, K Nakagawa, H Isobe, K Mori, K Matsui, N Saijo and T Tamura
Br J Cancer 98: 693-696; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604233
Parenteral oestrogen in the treatment of prostate cancer: a systematic review FREE
G Norman, M E Dean, R E Langley, Z C Hodges, G Ritchie, M K B Parmar, M R Sydes, P Abel and A J Eastwood
Br J Cancer 98: 697-707; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604230
Employment status and work-related difficulties in stomach cancer survivors compared with the general population FREE
M K Lee, K M Lee, J-M Bae, S Kim, Y-W Kim, K W Ryu, J H Lee, J-H Noh, T-S Sohn, S-K Hong and Y H Yun
Br J Cancer 98: 708-715; doi:10.1038/sj.bjc.6604236
A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study) FREE
J Stebbing, M Harrison, R Glynne-Jones, J Bridgewater and D Propper
Br J Cancer 98: 716-719; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604232
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis FREE
R Fruscio, N Colombo, A A Lissoni, A Garbi, R Fossati, N Ieda', V Torri and C Mangioni
Br J Cancer 98: 720-727; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604231
Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study FREE
L Mellemkjær, C Dahl, J H Olsen, L Bertelsen, P Guldberg, J Christensen, A-L Børresen-Dale, M Stovall, B Langholz, L Bernstein, C F Lynch, K E Malone, R W Haile, M Andersson, D C Thomas, P Concannon, M Capanu, J D Boice Jr, The WECARE Study Collaborative GroupJ L Bernstein
Br J Cancer 98: 728-733; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604228
High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies FREE
M A Bollet, A Savignoni, J-Y Pierga, M Lae, V Fourchotte, Y M Kirova, R Dendale, F Campana, B Sigal-Zafrani, R Salmon, A Fourquet and A Vincent-Salomon
Br J Cancer 98: 734-741; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604229
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer FREE
K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, S Tanaka, T Ishizuka, Y Kanai, H Endou, T Nakajima and M Mori
Br J Cancer 98: 742-748; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604235
Translational Therapeutics
Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status FREE
Y Akashi, I Okamoto, T Iwasa, T Yoshida, M Suzuki, E Hatashita, Y Yamada, T Satoh, M Fukuoka, K Ono and K Nakagawa
Br J Cancer 98: 749-755; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604222
CD44+CD24- prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis FREE
E M Hurt, B T Kawasaki, G J Klarmann, S B Thomas and W L Farrar
Br J Cancer 98: 756-765; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604242
Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer FREE
J T Korpi, V Kervinen, H Mäklin, A Väänänen, M Lahtinen, E Läärä, A Ristimäki, G Thomas, M Ylipalosaari, P Åström, C Lopez-Otin, T Sorsa, S Kantola, E Pirilä and T Salo
Br J Cancer 98: 766-775; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604239
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224) FREE
F Doñate, J C Juarez, M E Burnett, M M Manuia, X Guan, D E Shaw, E L P Smith, C Timucin, M J Braunstein, O A Batuman and A P Mazar
Br J Cancer 98: 776-783; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604226
Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge FREE
M J Grimshaw, K Papazisis, G Picco, H Bohnenkamp, T Noll, J Taylor-Papadimitriou and J Burchell
Br J Cancer 98: 784-791; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604221
20(S)-25-methoxyl-dammarane-3
, 12, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action FREE
W Wang, H Wang, E R Rayburn, Y Zhao, D L Hill and R Zhang
Br J Cancer 98: 792-802; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604227
Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt FREE
X Yang, M Fraser, M R Abedini, T Bai and B K Tsang
Br J Cancer 98: 803-808; doi:10.1038/sj.bjc.6604223
Interactions between microenvironment and cancer cells in two animal models of bone metastasis FREE
S Blouin, M F Baslé and D Chappard
Br J Cancer 98: 809-815; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604238
Molecular Diagnostics
MethCancerDB – aberrant DNA methylation in human cancer FREE
M Lauss, I Visne, A Weinhaeusel, K Vierlinger, C Noehammer and A Kriegner
Br J Cancer 98: 816-817; advance online publication, February 5, 2008; doi:10.1038/sj.bjc.6604219
Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV FREE
C de Micco, V Savchenko, R Giorgi, F Sebag and J-F Henry
Br J Cancer 98: 818-823; advance online publication, January 22, 2008; doi:10.1038/sj.bjc.6604194
SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis FREE
T Otsubo, Y Akiyama, K Yanagihara and Y Yuasa
Br J Cancer 98: 824-831; advance online publication, February 12, 2008; doi:10.1038/sj.bjc.6604193
Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer FREE
J Matsubara, T Nishina, Y Yamada, T Moriwaki, T Shimoda, T Kajiwara, T E Nakajima, K Kato, T Hamaguchi, Y Shimada, Y Okayama, T Oka and K Shirao
Br J Cancer 98: 832-839; advance online publication, January 29, 2008; doi:10.1038/sj.bjc.6604211
Genetics and Genomics
Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold FREE
E Anderson, J Berg, R Black, N Bradshaw, J Campbell, H Carnaghan, R Cetnarkyj, S Drummond, R Davidson, J Dunlop, A Fordyce, B Gibbons, D Goudie, H Gregory, S Holloway, M Longmuir, L McLeish, V Murday, Z Miedzybrodska, D Nicholson, P Pearson, M Porteous, M Reis, S Slater, K Smith, E Smyth, L Snadden, M Steel, D Stirling, C Watt, C Whyte and D Young
Br J Cancer 98: 840-844; doi:10.1038/sj.bjc.6604155
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers FREE
S M Alam, J Fujimoto, I Jahan, E Sato and T Tamaya
Br J Cancer 98: 845-851; advance online publication, January 29, 2008; doi:10.1038/sj.bjc.6604216
Letters to the Editor
Missing ligand model in autologous stem cell transplantation FREE
M Stern, M Paulussen, J Rischewski, A Tichelli and A Gratwohl
Br J Cancer 98: 852-853; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604153
Reply: Missing ligand model in autologous stem cell transplantation FREE
W Leung, R Handgretinger, V Turner and G A Hale
Br J Cancer 98: 854; advance online publication, December 18, 2007; doi:10.1038/sj.bjc.6604154
Book Review
Contemporary Issues in Cancer Imaging: Lung Cancer FREE
N Navani and S M Janes
Br J Cancer 98: 855; doi:10.1038/sj.bjc.6604173
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
